Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

GOLPH3L Inhibitors

GOLPH3L, also known as Golgi phosphoprotein 3-like, is a member of the Golgi phosphoprotein family, primarily localized to the trans-Golgi network (TGN) and involved in intracellular membrane trafficking processes. While the precise function of GOLPH3L remains to be fully elucidated, emerging evidence suggests its involvement in regulating protein transport between the Golgi apparatus and other cellular compartments. GOLPH3L shares structural homology with its closely related protein, GOLPH3, which has been implicated in the maintenance of Golgi structure and function, as well as in the coordination of vesicle trafficking. Similarly, GOLPH3L is hypothesized to play a role in mediating vesicle tethering or fusion events at the Golgi apparatus, thereby contributing to the efficient sorting and delivery of cargo molecules to their respective destinations within the cell.

Inhibition of GOLPH3L function can be achieved through various mechanisms aimed at disrupting its interactions with binding partners or interfering with its activity at the Golgi apparatus. One potential approach involves targeting the protein-protein interactions mediated by GOLPH3L, particularly those involved in vesicle trafficking and Golgi organization. Small molecules or peptides designed to mimic the binding interfaces of GOLPH3L's interacting partners may competitively inhibit these interactions, thereby preventing the recruitment or activation of GOLPH3L at the Golgi membrane. Additionally, modulation of post-translational modifications, such as phosphorylation or ubiquitination, may represent another strategy for inhibiting GOLPH3L function. By targeting key regulatory residues involved in GOLPH3L modification, it may be possible to disrupt its activity or localization within the Golgi apparatus, leading to aberrant membrane trafficking and cellular dysfunction.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K, which is involved in the signaling pathways that may interact with GOLPH3L function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Another PI3K inhibitor that can affect pathways potentially linked with GOLPH3L.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, a downstream target of PI3K, which can alter GOLPH3L-related processes.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor, may affect gene expression including that of proteins like GOLPH3L.

PF 4708671

1255517-76-0sc-361288
sc-361288A
10 mg
50 mg
$179.00
$700.00
9
(1)

Selective p70 S6 kinase inhibitor, downstream of PI3K/mTOR pathway, may indirectly affect GOLPH3L.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, could alter signaling pathways where GOLPH3L plays a role.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, could modify cellular processes involving GOLPH3L indirectly.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor, potentially affecting pathways associated with GOLPH3L indirectly.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Another MEK inhibitor, which may have an indirect effect on GOLPH3L-related signaling.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts Golgi function, and while not specific, could affect GOLPH3L by altering Golgi dynamics.